ChangeM – The Project Change Management Software

ChangeM by goPLIMS is a centralised, digital Change Management platform that provides a consistent, systematic, and fully traceable approach to formally raising, evaluating, approving, implementing, and closing out changes across projects and operations. Unlike email-based change processes — where change requests get lost in inboxes, approvals are given informally, and implementation evidence is never centralised — ChangeM enforces a structured, sequenced workflow for every change from first submission to formal close-out. Critically, ChangeM is incorporated with digital signature capability, enabling both pre-approvals and post-approvals to be captured electronically by the right stakeholders, in the right sequence, with a complete and tamper-evident audit trail. All supporting documents, drawings, and attachments are stored centrally against the change record — eliminating the version control failures and missing evidence that routinely cause compliance issues in paper-based systems.

ChangeM is built around three pillars that reflect the complete lifecycle of any formally managed change. Submit: the change initiator specifies all details of the proposed change — its description, rationale, scope, impact category, all documents and drawings affected, and the full list of stakeholders required for pre-approval. Electronic signatures are sequenced at this stage to ensure the change is formally evaluated and approved before any implementation work begins — preventing unauthorised or premature execution. Implement: once pre-approved, the change is implemented in the defined sequence. All relevant drawings and documents are updated, proof of all completed implementation actions is collated and attached to the record, and the live status of the change is monitored in real time by all stakeholders. Close-Out: before a change can be formally closed, all deliverables are verified and confirmed as complete. Post-approval electronic signatures are sequenced from the relevant authorities, and the full change record — including all evidence, approvals, and references — is indexed and maintained as a permanent, retrievable compliance record.

In pharmaceutical projects and operations, the sequencing and documentation of approvals is not a formality — it is a regulatory requirement. ChangeM’s integrated digital signature capability allows organisations to define and enforce a structured, sequenced approval chain for every change record. At the pre-approval stage, the initiator identifies all stakeholders required to review and approve the change before implementation begins — which may include Engineering, Quality Assurance, Regulatory Affairs, and Management, depending on the change category. Each approver receives a notification, reviews the change record with all its attachments, and applies their electronic signature in sequence. At the post-approval stage, once implementation is complete and all evidence is attached, a further sequence of signatures confirms that the change has been correctly implemented, verified, and closed. This two-stage, sequenced electronic signature model directly supports the requirements of 21 CFR Part 11, EU Annex 11, and GMP change control procedures — making ChangeM a compliant-by-design platform rather than one that requires retrofitting for regulatory use.

Change control is one of the most heavily scrutinised areas of GMP compliance. Regulatory authorities including the FDA, EMA, and HPRA expect pharmaceutical organisations to demonstrate that all changes — whether to processes, equipment, materials, facilities, or documentation — are formally evaluated, approved before implementation, correctly executed, and verified at close-out. ChangeM is purpose-designed to satisfy these expectations. Every change record captures the full description and rationale, an impact category classification, a list of all affected documents and drawings, a pre-approval signature sequence, an implementation record with proof of completion, and a post-approval signature sequence at close-out. All activities are automatically logged with timestamps, user identities, and status changes — creating an audit trail that is available at any time for internal quality reviews, regulatory inspections, or Pre-Approval Inspections (PAI). For pharma teams managing Change Control as part of their Quality Management System, ChangeM provides the digital infrastructure to demonstrate that every change was controlled, governed, and documented in full compliance with regulatory expectations.

One of the most common failures in change management is the incomplete identification of all documents and drawings affected by a change — leading to out-of-date drawings being used on-site, superseded SOPs remaining in circulation, or qualification documents reflecting conditions that no longer exist. ChangeM addresses this directly at the submission stage. When a change is initiated, the submitter is required to list all documents and drawings impacted by the change as part of the formal change record. These references are captured centrally and remain linked to the change throughout its lifecycle — from pre-approval through implementation to close-out. At the implement stage, the update status of each affected document and drawing is tracked, and evidence of the updates is collated and attached to the change record. At close-out, all document and drawing updates are verified before the final post-approval signatures are applied. This structured document impact management process ensures that no affected document is missed, and that the change record serves as a complete, traceable reference for all associated updates.

Not all changes carry the same risk or require the same level of scrutiny. ChangeM allows each change to be categorised by its impact — for example, Minor, or Major, or using a project-specific classification framework — at the point of submission. This categorisation drives the appropriate level of review and approval required: a minor administrative change may require a simple two-signature pre-approval, while a major change to a validated process or a GMP-critical system may require a full cross-functional review including QA, Engineering, Regulatory Affairs, and Senior Management. In pharma specifically, categorising changes correctly is a regulatory expectation — authorities expect to see evidence that impact categories are defined, consistently applied, and linked to a proportionate approval process. In engineering and construction projects, impact categorisation enables Project Managers to distinguish between routine scope adjustments and changes that carry schedule, cost, or qualification impact — allowing resources and governance effort to be proportionate to risk.

ChangeM provides four views that give project teams and quality functions real-time visibility of change status at the level of detail they need. Summary View presents an at-a-glance overview of all change records — how many are open, awaiting pre-approval, in implementation, pending post-approval, or formally closed — giving Programme Managers and QA Directors an instant picture of the change landscape without navigating individual records. List View displays a fully sortable and filterable table of all changes, organised by category, status, owner, date, or any other relevant field — ideal for weekly change review meetings, governance reporting, and inspection preparation. Calendar View maps all change implementation deadlines and close-out targets onto a calendar, enabling teams to identify deadline clusters, resource conflicts, and at-risk changes before they become schedule problems. Draft Tab allows incomplete change submissions to be saved and returned to — ensuring that no change is formally submitted before it is fully and accurately documented.

ChangeM is designed so that audit readiness is not a preparation exercise — it is a permanent state. Every action taken within a change record is automatically logged with a timestamp, a user identity, and a status descriptor, creating a continuously updated, tamper-evident audit trail that requires no manual compilation. At any point — whether for an internal quality review, a supplier audit, or a regulatory inspection — a complete change record can be retrieved and exported, showing the full history of the change from initial submission through every approval, every implementation update, every document reference, and every close-out signature. Customised change reports can be generated and exported to PDF or Excel for inclusion in regulatory submission packages, inspection binders, or change control summary reports for steering committees. For pharmaceutical organisations subject to FDA, EMA, or HPRA oversight, this level of readily available, structured documentation is what separates a confident inspection response from a finding.

In large pharma or engineering programmes, change approval often requires input from stakeholders across different departments, organisations, time zones, and geographies — making sequential paper-based or email-based approval processes slow, unreliable, and difficult to track. ChangeM resolves this by centralising the entire approval process on a single cloud-based platform accessible 24 hours a day from any location. The sequenced digital signature workflow means that each approver is notified automatically when it is their turn to review and sign — removing the need for manual chasing and ensuring the approval chain progresses without bottlenecks. All approvers see the same complete change record, including all attachments, impact assessments, and previous approvals — eliminating the confusion that arises when different stakeholders are working from different versions of a document. For multinational pharma companies managing changes across manufacturing sites in multiple countries, or for project consortia involving owner, contractor, and regulatory representatives, ChangeM provides the governance infrastructure to manage cross-boundary approvals consistently and compliantly.

ChangeM is a core module within the goPLIMS Integrated Project Execution Platform and is designed to connect with the broader suite to provide complete traceability from change initiation to close-out and beyond. A change that originates from an open punch item in PunchM can be formally linked, ensuring that the physical defect and the governing change record are connected in a single audit trail. Information clarifications needed to define the scope of a change can be tracked in RFI-M. Actions arising from a change — drawing updates, procedure revisions, equipment modifications — can be assigned and tracked to closure in ActionR. Documents referenced or updated as part of a change can be version-controlled and managed in EDocM. Discrepancies or deviations arising from change implementation can be captured in DiscrepM. This end-to-end connectivity means that a change does not live in isolation — it is embedded within the full project execution record, with every related defect, query, action, document, and deviation traceable from a single, governed platform. For pharma organisations building a comprehensive digital quality and project execution environment, ChangeM is the change control backbone that links every event to a formally managed and documented outcome.

Yes, ChangeM supports the digitalisation of deviation and exception management by providing a structured, compliant workflow to manage change-related deviations and controlled updates.

In pharmaceutical and regulated environments, deviations and exceptions often lead to formal change processes. ChangeM enables teams to capture these changes, assess impact, assign responsibilities, and track them through a controlled lifecycle—from initiation to approval and closure.

Each change record is:

• Fully traceable with time-stamped actions and approvals
• Linked to relevant deviations, risks, and project activities
• Managed through defined workflows aligned with change control procedures

With role-based access control, only authorised users can initiate, review, approve, or close changes—ensuring compliance with internal governance and regulatory expectations.

By digitising change and exception workflows, ChangeM eliminates manual tracking, improves transparency, and ensures that all deviations leading to change are properly assessed, documented, and audit-ready.

Yes, ChangeM supports knowledge management by capturing all change records, decisions, impact assessments, and approvals in a structured and centralised system.

In pharma projects and operations, change control processes generate critical knowledge—why a change was made, what risks were assessed, and how it was resolved. ChangeM ensures this information is retained and easily accessible for future reference.

This enables teams to:

• Review historical changes and their outcomes
• Improve future decision-making and risk assessments
• Ensure consistency across similar projects and processes

With structured workflows, searchable records, and role-based dashboards, ChangeM transforms change control data into a valuable organisational knowledge asset.

By embedding knowledge capture into change management processes, organisations can move beyond compliance to continuous improvement, better governance, and more informed project execution.